VIP-deficient mice show significant changes in gut microbiome composition, reduced biodiversity, and weight loss, with microbial profiles resembling those seen in inflammatory and autoimmune disorders.
47 mice, both sexes affectedVIP deficiency restructured the gut microbiome regardless of sex, with changes resembling inflammatory and autoimmune disease patterns
What the researchers found
VIP knockout mice (VIP-/-) showed significant changes in gut bacterial composition, reduced biodiversity, and weight loss compared to wild-type (VIP+/+) and heterozygous (VIP+/-) littermates, regardless of sex. The altered microbiome profile in VIP-deficient mice resembled microbial changes reported in inflammatory and autoimmune disorders. Predictive functional analysis using PICRUSt software suggested an energy surplus within the altered microbiota, indicating shifts in bacterial metabolic function. These effects were consistent across 47 mice of both sexes.
Why it matters
The gut microbiome profoundly influences health, from immune function to metabolism and mental health. Showing that a single neuropeptide — VIP — is essential for maintaining normal gut bacterial communities establishes a direct link between the nervous system's peptide signaling and microbiome homeostasis. This could have implications for understanding conditions where VIP signaling is disrupted, including inflammatory bowel disease, autoimmune disorders, and neurodegenerative diseases.
How the study worked
Researchers collected fecal samples from 47 mice across three genotypes (VIP+/+, VIP+/-, and VIP-/-) of both sexes, all from the same litters to control for environmental and maternal effects. They performed 16S rRNA gene sequencing to characterize gut bacterial communities and used PICRUSt software to predict functional changes in the microbiome. Body weight was also tracked.
What this study cannot tell us
This study used a genetic knockout model where VIP is absent from birth, which may trigger developmental compensatory changes not relevant to adult VIP dysfunction. The 16S rRNA sequencing identifies bacterial taxa but doesn't directly measure their functional effects. PICRUSt predictions are computational estimates, not direct measurements of microbial metabolism. The mouse gut microbiome differs from the human microbiome, so the specific bacterial changes may not translate directly.
How to read the evidence
This is a well-controlled preclinical study using littermate controls of three genotypes with 16S rRNA sequencing. The use of littermates strengthens the evidence by controlling for environmental factors. However, it remains a mouse model with computational (not direct) functional predictions.
When this study was published
Published in 2019, this study reflects the growing interest in neuropeptide-microbiome interactions. The field has expanded significantly since, with more research on how peptide signaling shapes microbial ecology.
The bigger picture
The connection between neuropeptides and the gut microbiome is an emerging frontier in biomedical research. VIP is part of the gut-brain axis — the bidirectional communication system between the nervous system and the gastrointestinal tract. This study provides some of the first direct evidence that a specific neuropeptide is required to maintain normal gut microbial ecology. As microbiome-based therapies gain traction for various diseases, understanding how peptide signaling shapes microbial communities could inform new treatment strategies.
Questions still open
- Could VIP supplementation restore normal gut microbiome composition in conditions where VIP signaling is reduced?
- Do patients with inflammatory bowel disease or autoimmune disorders show reduced VIP levels alongside their altered microbiomes?
- Is the weight loss in VIP-deficient mice caused by the altered microbiome, the loss of VIP's metabolic functions, or both?
Common questions
What is vasoactive intestinal peptide (VIP) and what does it do in the gut?
How does losing one peptide change the entire gut microbiome?
Read the original research
Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice.
Frontiers in microbiology, 10, 2689
Citation
Bains, Manpreet; Laney, Caleb; Wolfe, Annie E; Orr, Megan; Waschek, James A; Ericsson, Aaron C; Dorsam, Glenn P. (2019). Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice.. Frontiers in microbiology, 10, 2689. https://doi.org/10.3389/fmicb.2019.02689